Skip to content

Malnutrition and outcome in hospitalized children in Europe (ESPEN Network Grand Project)

Malnutrition and outcome in hospitalized children in Europe (ESPEN Network Grand Project) - Malnutrition in hospitalized children

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON34719
Enrollment
220
Registered
2010-06-03
Start date
2010-06-07
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ondervoeding/slechte voedingstoestand disease related malnutrition malnutrition

Interventions

None listed

Sponsors

Erasmus MC, Universitair Medisch Centrum Rotterdam
Lead Sponsor

Eligibility

Age
2 Years to 17 Years

Inclusion criteria

Inclusion criteria: •Children admitted to the participating hospitals during the study period •Age between 1 month and 18 years •Expected hospital stay exceeding 24 hours •Parents/caregivers, as well as those patients capable to comprehend, agree to participation and sign the informed consent form

Exclusion criteria

Exclusion criteria: •Infants with premature birth (= 18 years of age •Children in need of intensive care •Children admitted to day-care (LOS

Design outcomes

Primary

MeasureTime frame
The primary outcome of the trial will be the length of hospital stay (days).

Secondary

MeasureTime frame
The secondary outcomes are: • change of anthropometry during stay (e.g. percent weight loss per hospital day, based on difference between admission weight and discharge weight) • frequency of infectious complications (number of days with temperature >38,5°C, number of days with days with antibiotic use) • frequency of gastrointestinal complications (number of days with vomiting, number of days with diarrhoea) • muscle strength (kids >= 6 years) • number of days with need for nutritional support during stay in any form, in addition to any prior to admission

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)